A cellular traffic jam appears to affect neurons in most forms of ALS (amyotrophic lateral sclerosis), researchers have shown. The findings suggest that a drug strategy aimed at easing the traffic jam may be generalizable to sporadic and at least some familial types of ALS and FTD (frontotemporal dementia).